Advertisement

Topics

Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late

10:55 EST 13 Nov 2017 | Labiotech.eu

GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is a biotech, which spun-out from the Catalan Institute of Cardiovascular Science. The startup focuses on the development of an in vitro ...

This awesome article Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late

NEXT ARTICLE

More From BioPortfolio on "Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...